Shuanghe Peng

523 citations
23 papers · 379 indexed · h-index 13
Topics
Renal cell carcinoma treatment (9 papers)Cancer, Hypoxia, and Metabolism (9 papers)Renal and related cancers (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Shuanghe Peng

23 papers receiving 374 citations

Peers

Shuanghe Peng
Comparison fields: 5 of 52
  • Pulmonary and Respiratory Medicine 197
  • Cancer Research 171
  • Molecular Biology 168
  • Oncology 150
  • Surgery 65
Replace Renzo G. DiNatale with:
Renzo G. DiNatale United States
Alessandra Modena Italy
Luke J. Lee United States
Raffaele Piscitelli Italy
Kaiqi Du China
Youcai Zhao China
Eduardo Caetano Albino da Silva Brazil
Salma Alam United Kingdom
Karla Alvarez United States
Zhaofei Pang China
Shuanghe Peng relative to Renzo G. DiNatale United States Renzo G. DiNatale's profile →
Citations per field
00.5×10×16.5×
Renzo G. DiNatale · 1×
Citations per year

Countries citing papers authored by Shuanghe Peng

Since Specialization
Citations

This map shows the geographic impact of Shuanghe Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuanghe Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuanghe Peng more than expected).

Fields of papers citing papers by Shuanghe Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuanghe Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuanghe Peng. The network helps show where Shuanghe Peng may publish in the future.

Co-authorship network of co-authors of Shuanghe Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Shuanghe Peng. A scholar is included among the top collaborators of Shuanghe Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuanghe Peng. Shuanghe Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 4
3 3
4 10
5 13
6 10
7 6
8 42
9 11
10 31
11 20
12 37
13 15
14 12
15 29
16 18
17 14
18 9
19 9
20 24

About Shuanghe Peng

Shuanghe Peng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 23 papers that have together received 379 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Cancer Research (171 citations), Pulmonary and Respiratory Medicine (197 citations) and Oncology (150 citations). Shuanghe Peng has collaborated with scholars based in China and United States. Frequent co-authors include Zhun Wang, Xianghui Ning, Kan Gong, Jiangyi Wang, Ning Jiang, Hui Xie, Yuanjie Niu, Zhiqun Shang, Aixiang Wang and Jinchao Chen. Their work appears in journals such as Cancer Research, Clinica Chimica Acta and Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026